Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

A-385358 is an inhibitor of Bcl-xL (Ki = 0.8 nM).1 It is selective for Bcl-xL over Bcl-2 (Ki = 67 nM). A-385358 decreases the proliferation of NCI H146 small cell lung carcinoma, MOLT-4 T lymphoblast, and CCRF CEM lymphoblastic leukemia cells in serum-free media (IC50s = 0.35, 0.74, and 0.21 µM, respectively). In vivo, A-385358 (100 mg/kg per day) in combination with paclitaxel (Item No. 10461) reduces tumor growth in an A549 lung cancer mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. A small-